首页> 外文期刊>British Journal of Cancer >Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1|[sol]|2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1|[sol]|BRCA2
【24h】

Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1|[sol]|2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1|[sol]|BRCA2

机译:在BRCA1 | [sol] | 2突变携带者中评估XRCC1基因作为表型修饰子。 BRCA1 | [sol] | BRCA2修饰剂研究人员财团的结果

获取原文
获取外文期刊封面目录资料

摘要

Background:Single-nucleotide polymorphisms (SNPs) in genes involved in DNA repair are good candidates to be tested as phenotypic modifiers for carriers of mutations in the high-risk susceptibility genes BRCA1 and BRCA2. The base excision repair (BER) pathway could be particularly interesting given the relation of synthetic lethality that exists between one of the components of the pathway, PARP1, and both BRCA1 and BRCA2. In this study, we have evaluated the XRCC1 gene that participates in the BER pathway, as phenotypic modifier of BRCA1 and BRCA2.
机译:背景:参与DNA修复的基因中的单核苷酸多态性(SNP)是作为高风险易感性基因BRCA1和BRCA2中突变携带者的表型修饰剂而被测试的良好候选者。鉴于该途径的一种组分PARP1与BRCA1和BRCA2两者之间都存在合成致死性的关系,碱基切除修复(BER)途径可能特别有趣。在这项研究中,我们评估了参与BER途径的XRCC1基因,作为BRCA1和BRCA2的表型修饰剂。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号